Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Feb 26.
Published in final edited form as: Gynecol Oncol. 2012 Mar 17;125(3):556–560. doi: 10.1016/j.ygyno.2012.03.020

Impact of Smoking on Perioperative Pulmonary and Upper Respiratory Complications after Laparoscopic Gynecologic Surgery

Whitney S Graybill a, Michael Frumovitz b, Alpa M Nick b, Caimiao Wei c, Gabriel E Mena d, Pamela T Soliman b, Ricardo dos Reis e, Kathleen M Schmeler b, Pedro T Ramirez b,*
PMCID: PMC3935604  NIHMSID: NIHMS530239  PMID: 22433464

Abstract

OBJECTIVE

To determine the impact of smoking on the rate of pulmonary and upper respiratory complications following laparoscopic gynecologic surgery.

METHODS

We retrospectively identified all patients who underwent laparoscopic gynecologic surgery at one institution between January 2000 and January 2009. Pulmonary and upper respiratory complications were defined as atelectasis, pneumonia, upper respiratory infection, acute respiratory failure, hypoxemia, pneumothorax, or pneumomediastinum occurring within 30 days after surgery

RESULTS

Nine hundred three patients underwent attempt at laparoscopic surgery. Fifty-four were excluded because of conversion to laparotomy and 31 because of insufficient data. Of the 818 patients included, 356 (43%) had cancer. A total of 576 (70%) patients were never smokers, 156 (19%) were past smokers, and 86 (10%) were current smokers (smoked within 6 weeks before surgery). These three groups were similar with regard to median body mass index, operative time, and length of hospital stay. Compared to never and past smokers, current smokers were more likely to undergo high-complexity laparoscopic procedures (10.4%, 15.4%, and 19.8%, respectively; p=0.015) and had younger median age 49 years, 51 years, and 46 years, respectively; p=0.035. Nineteen (2.3%) patients experienced pulmonary complications - symptomatic atelectasis (n=9), pneumonia (n=5), acute respiratory failure (n=2), hypoxemia (n=1), pneumomediastinum (n=1), and pneumothorax (n=2). The rate of pulmonary complications was 2.1% (12 of 564 patients) in never smokers, 4.5% (7 of 156 patients) in past smokers, and zero in current smokers.

CONCLUSION

In this cohort, smoking history did not appear to impact postoperative pulmonary and upper respiratory complications. In smokers scheduled for operative procedures, laparoscopy should be considered when feasible.

Keywords: Smoking, laparoscopic gynecologic surgery, pulmonary complications

INTRODUCTION

Cigarette smoking is the number one cause of preventable mortality in the United States. It accounts for more than 440,000 deaths annually [1]. Approximately one third of surgical patients are smokers [2], and cigarette smoking has been repeatedly proven to be an important risk factor for postoperative complications [36]. Smokers have an increased risk of circulatory, pulmonary, and infectious complications and postoperative admission to the intensive-care unit [5].

Cigarette smoking is a known risk factor for postoperative pulmonary complications. Pulmonary complications following abdominal surgery are frequent and associated with increased morbidity and mortality and length of hospital stay [79]. In addition to smoking, factors associated with an increased risk of developing pulmonary complications after surgery include preexisting chronic lung disease, abnormal pulmonary function tests, age > 60 years, upper abdominal or thoracic surgery, obesity, and anesthesia time > 3 hours [1013]. Studies have shown that current smokers, defined as having smoked within two to six weeks of surgery, are two to six times more likely than current nonsmokers to develop postoperative pulmonary complications [3, 14, 15]. This increased risk may be associated with smoking-induced chronic pulmonary changes such as small airway narrowing, increased closing capacity, impaired tracheobronchial clearance of pulmonary secretions, and chronic obstructive pulmonary disease (COPD) [16].

To date, studies evaluating the effects of preoperative smoking on postoperative pulmonary complications have focused on surgical patients undergoing laparotomy. There is limited information available regarding pulmonary complications in surgical patients undergoing abdominal laparoscopic procedures. The purpose of this study was to evaluate the effects of preoperative smoking on postoperative pulmonary and upper respiratory complications in patients undergoing laparoscopic gynecologic surgery.

MATERIALS AND METHODS

After receipt of Institutional Review Board approval, data were retrospectively collected on patients who underwent laparoscopic gynecologic surgery at The University of Texas MD Anderson Cancer Center between January 2000 and January 2009. Exclusion criteria included conversion to laparotomy and nonelective surgery. Data concerning smoking status and postoperative pulmonary complications were obtained from review of medical records. Current smokers were defined as individuals having smoked at least within 6 weeks before surgery. Past smokers were defined as those having smoked but not within 6 weeks before surgery. Never smokers were defined as those who had never smoked. Six weeks was chosen to separate current from past smokers on the basis of studies suggesting an improvement in postoperative pulmonary function with smoking cessation at least 6–8 weeks prior to elective surgery [2, 17, 18]. Unfortunately, length of smoking time was documented in fewer than 50% of patients and therefore not available for analysis. In addition, we were unable to capture the amount of smoking in the previous smokers and current smokers group. Pulmonary complications were defined as symptomatic atelectasis (cough, chest pain, breathing difficulty, or evidence of low oxygen saturation and chest x-ray showing incomplete expansion as evidenced by diminished volume), pneumonia, upper respiratory infection, such as bronchitis or sinusitis, acute respiratory failure, hypoxemia with O2 saturation less than 90%, pneumothorax, or pneumomediastinum occurring within 30 days after surgery.

Preoperative risk factors of interest were identified from the literature on postoperative pulmonary complications and included age, body mass index (BMI), smoking history, preoperative diagnosis, and history of comorbid conditions such as diabetes, chronic heart disease, and COPD [3, 12, 19]. We do not routinely perform pulmonary function tests prior to laparoscopy, so this parameter was not included in our analysis. Patients were grouped into three categories of surgical complexity: low, medium, and high. Low-complexity procedures included diagnostic and second-look laparoscopy. High-complexity procedures included radical hysterectomy, lymphadenectomy, splenectomy, and bowel resection. All remaining procedures were considered intermediate complexity. Additional extracted data included estimated mean blood loss, operative time, and length of hospital stay. Our study included a sample size of 576 non-smokers, 176 former smokers, and 86 current smokers. With this sample size we had >80% power to detect non-inferiority for the former smokers and current smokers as compared to non-smokers. Categorical variables were summarized using frequencies and percentages. Mean, median, and range were used to summarize continuous variables. Chi-square tests or Fisher’s exact tests were used when appropriate to assess the association between categorical variables. Wilcoxon rank-sum or Kruskal-Wallis test was used to assess the association between continuous variables, smoking status, and the presence of postoperative pulmonary complications. A p value < 0.05 was considered statistically significant.

RESULTS

We identified 903 consecutive patients who underwent an attempt at laparoscopic gynecologic surgery at MD Anderson during the study period. Fifty-four of these patients were excluded because of conversion to laparotomy, and 31 patients were excluded because of insufficient follow-up data. A total of 818 patients were eligible for evaluation. The median age of the patients was 49 years, (range; 12–88) and the median BMI 26.5 kg/m2 (range; 14.2–72.3). A total of 356 (43%) patients had a diagnosis of cancer. Twenty-four (2.9%) patients had chronic heart disease, 2 (0.2%) patients had COPD, and 66 (8%) patients had diabetes. A total of 576 (70%) patients were never smokers, 156 (19%) patients were past smokers, and 86 (10%) patients were current smokers. A majority of patients (78.3%) underwent laparoscopic surgical procedures of intermediate complexity, followed by high (12.5%) and low surgical complexity (9.2%). The median length of hospital stay was 1 day (Table 1).

Table 1.

Perioperative Patient Characteristics

Variable Levels No. of
patients
% of patients
- - 818 -
Chronic heart disease No 794 97.1
Yes 24 2.9
Chronic obstructive pulmonary disease No 816 99.8
Yes 2 0.2
Diabetes No 752 92
Yes 66 8
Smoking status Current smoker 86 10.5
Never smoker 576 70.2
Former smoker 156 19
Disease Carcinoma 356 43
Benign 462 57
Atelectasis No 809 98.9
Yes 9 1.1
Pneumonia No 813 99.4
Yes 5 0.6
Acute respiratory failure No 816 99.8
Yes 2 0.2
Hypoxemia No 817 99.9
Yes 1 0.1
Pneumomediastinum No 817 99.9
Yes 1 0.1
Pneumothorax No 816 99.8
Yes 2 0.2
Any pulmonary complication No 799 97.7
Yes 19 2.3
Hospital length of stay, days 0 200 25
1 335 40.9
2 194 23.8
3 55 6.7
≥4 34 3.6
Surgical complexity - - -
Low Diagnostic laparoscopy 33 9.2
Second-look laparoscopy 42
Intermediate Unilateral or bilateral salpingooophorectomy 202
Unilateral or bilateral ovarian cystectomy 10
Ovarian transposition 4 78.3
Bilateral tubal ligation 9
Hysterectomy and unilateral or bilateral 415
salpingo-oophorectomy
High Radical hysterectomy 34
Pelvic and/or paraaortic 64
Lymphadenectomy 12.5
Splenectomy 3
Small bowel or colon resection 2
Median age at diagnosis (range), years - 818 49 (12, 88)
Median BMI (range), kg/m2 - 812 26.5 (14.2, 72.3)
Median operative time (range), min - 756 177(26, 734)
Median blood loss (range), mL - 818 50 (10, 1000)
Median length of hospital stay (range), days - 818 1 (0, 13)

Nineteen (2.3%) patients experienced pulmonary complications. The most frequent pulmonary complication was symptomatic and radiologically documented atelectasis (n=9, or 1.1%). Additional pulmonary complications included pneumonia (n=5), acute respiratory failure (n=2), hypoxemia (n=1), pneumomediastinum (n=1), and pneumothorax (n=2). Of note, one patient had both hypoxemia and pneumomediastinum. The two patients who developed acute respiratory failure in the postoperative period underwent laparoscopic hysterectomy and bilateral salpingo-oophorectomy for endometrial carcinoma. The first patient was a never smoker and had no significant medical comorbidities but did have an operative time of 358 minutes due to extensive lysis of adhesions. She had a complete recovery following a brief admission to the intensive care unit. The second patient with acute respiratory failure had several medical comorbidities (hypothyroid, atrial fibrillation, and morbid obesity [BMI = 70.8 kg/m2]) and was a past smoker. She underwent a radical hysterectomy and pelvic lymphadenectomy for cervical cancer. The operative time was 420 minutes. She was then re-admitted 1 week later with acute respiratory failure, acute renal failure, and sepsis due to possible bowel perforation. She subsequently died. The patient who developed both hypoxemia and pneumomediastinum in the postoperative period underwent a radical hysterectomy and pelvic lymphadenectomy for cervical cancer. She had an operative time of 420 minutes and was a past smoker. The pneumomediastinum ultimately resolved within 5 days of surgery.

Perioperative patient variables by smoking status are summarized in Tables 2 and 3. There was no difference in median BMI (26.5 vs. 26.3 vs. 26.6; p=0.45), median operative time (174 min vs. 190 min vs. 183 min; p=0.80), and median length of hospital stay (1 day for all groups; p=0.95) among never smokers, past smokers, and current smokers. Current smokers were significantly younger (46 yrs) than never smokers and past smokers (49 yrs and 51 yrs); respectively (p = 0.035) (Table 2). Current smokers were also more likely than never smokers and past smokers to undergo laparoscopic procedures with high surgical complexity (19.8% vs. 15.4% vs. 10.4%; p=0.015) (Table 3). The rate of pulmonary complications was 2.1% (12 of 576 patients) among never smokers, 4.5% (7 of 156 patients) among past smokers, and zero among current smokers. Similarly, smoking history did not increase the risk of postoperative pulmonary complications among cancer patients.

Table 2.

Continuous Variables by Smoking Status

Variable Smoking status No. of patients Median
(range)
Kruskal-
Wallis p
Age at diagnosis, years Never smoker 576 49 (12, 88) 0.035
Past smoker 156 51 (24, 81) .
Current smoker 86 46 (25, 80) .
BMI, kg/m2 Never smoker 570 26.5 (14.2, 59.4) 0.447
Past smoker 155 26.3 (16.8, 72.3) .
Current smoker 84 26.6 (19.2, 54.3) .
Operative time, minutes Never smoker 530 174 (26, 684) 0.804
Past smoker 146 189.5 (36, 526) .
Current smoker 80 182.5 (50, 734) .
Blood loss, mL Never smoker 575 75 (0, 1000) 0.054
Past smoker 15 50 (0, 800) .
Current smoker 86 50 (5, 800) .
Length of hospital stay, days Never smoker 576 1 (0, 13) 0.954
Past smoker 156 1 (0, 6) .
Current smoker 86 1 (0, 13) .

Table 3.

Categorical Variables by Smoking Status

Covariate Levels Never
smokers,
no. of
patients (%)
Past
smokers,
no. of
patients (%)
Current
smokers,
no. of
patients (%)
Chi-
square
p
Fisher's
exact
test p
Chronic heart disease No 564 (97.9) 149 (96.5) 81 (94.2) -- 0.482
Yes 12 (2.1) 7 (4.5) 5 (5.8) . .
Chronic obstructive pulmonary No 576 (100) 154 (98.7) 86 (100) -- 0.047
disease Yes 2 (1.3) . .
Diabetes No 525 (91.1) 148 (94.9) 79 (91.9) 0.317 --
Yes 51 (8.9) 8 (5.1) 7 (8.1) . .
Atelectasis No 569 (98.8) 154 (98.7) 86 (100) -- 0.756
Yes 7 (1.2) 2 (1.3) . .
Pneumonia No 573 (99.5) 154 (98.7) 86 (100) 0.322
Yes 3 (0.5) 2 (1.3) . .
Acute respiratory failure No 575 (99.8) 155 (99.4) 86 (100) -- 0.504
Yes 1 (0.2) 1 (0.6) . .
Hypoxemia No 576 (100) 155 (99.4) 86 (100) -- 0.296
Yes 1 (0.6) . .
Pneumomediastinum No 576 (100) 155 (99.4) 86 (100) -- 0.296
Yes 1 (0.6) . .
Pneumothorax No 575 (99.8) 155 (99.4) 86 (100) -- 0.504
Yes 1 (0.2) 1 (0.6) . .
Any pulmonary complication No 564 (97.9) 149 (95.5) 86 (100) -- 0.082
Yes 12 (2.1) 7 (4.5)
Length of hospital stay, days 0 148 (25.7) 36 (23.1) 16 (18.6) 0.521
1 227 (39.4) 65 (41.7) 43 (50) .
2 133 (23.1) 42 (26.9) 19 (22.1) .
3 44 (7.6) 7 (4.5) 4 (4.7) .
≥4 24 (4.2) 6 (3.8) 4 (4.7) .
Surgical complexity Low 47 (8.2) 21 (13.5) 7 (8.1) 0.015
Intermediate 469 (81.4) 111 (71.2) 62 (72.1)
High 60 (10.4) 24 (15.4) 17 (19.8)
Age <49 286 (49.7) 65 (41.9) 49 (57) 0.06
≥49 290 (50.3) 90 (58.1) 37 (43)
Operative time, min <200 317 (59.8) 79 (54.1) 47 (58.8) 0.464
≥200 213 (40.2) 67 (45.9) 33 (41.3)

We did not find an association between diabetes or chronic heart disease and smoking history or development of pulmonary complications. Both of the patients with COPD had a past history of smoking (p=0.046), and one developed a postoperative pulmonary complication. In univariable analysis, the only risk factors associated with the development of postoperative pulmonary complications were older age, longer operative time, and history of COPD. In multivariable logistic regression model with all these 3 factors being included, history of COPD remains a significant predictor of postoperative pulmonary complications (p=0.028). Age (p=0.057) and operative time (p=0.0503) were marginal predictors (Table 4).

Table 4.

Perioperative Pulmonary Complications

Variable Levels No Pulmonary
Complication
Any Pulmonary
Complication
p*
Median age (range), years - 49 (12, 88) 55 (30,83) 0.023
N=799 N=19
Median BMI (range), kg/m2 - 26.5 (14.2, 72.3) 27.4 (18.2, 70.8) 0.666
N=793 N=19
Median operating time (range), min - 175 (26, 734) 217 (36, 420) 0.042
N=737 N=19
Median blood loss (range), mL - 50 (0, 1000) 50 (10, 700) 0.85
N=799 N=19
Median length of hospital stay (range), days - 1 (0, 13) 3 (1, 8) < 0.0001
N=799 N=19
Chronic heart disease, no. of patients (%) No 776 (97) 18 (94.7) 0.435
Yes 23(3) 1 (5.3)
Chronic obstructive pulmonary disease, no. of patients (%) No 799 (99.9) 18 (94.7) 0.046
Yes 1 (0.1) 1 (5.3)
Diabetes, no. of patients (%) No 735 (92) 17 (89.5) 0.66
Yes 64 (8) 2 (10.5)
*

Based on Wilcoxon rank-sum test for continuous variables and Fisher’s exact test for categorical variables.

Based on an average age of 49 years and operative time of 175 minutes for patients who did not develop postoperative pulmonary complications, we chose cut points to evaluate an age or operative time above which the risk for laparoscopic surgery may be too great. Age over 49 years and operative time over 200 minutes did not significantly increase the risk of a pulmonary complication (Table 3). Patients who developed postoperative pulmonary complications had a significantly longer median length of hospital stay than those who did not (3 vs. 1 days, p<0.0001) (Table 4).

DISCUSSION

The key finding of the current study is that in this cohort of patients, smoking history did not impact the rate of postoperative pulmonary complications after laparoscopic surgery. When we controlled for confounding variables, the only risk factors for the development of postoperative pulmonary complications was a history of COPD. The development of a pulmonary complication translated into a significantly longer hospital stay.

In retrospective and prospective studies of patients undergoing abdominal laparotomy, several risk factors for postoperative pulmonary complication have been consistently identified, including increased duration of surgery, older age, obesity, history of cardiac disease, COPD, and history of smoking [8, 9, 13]. In the current study, a diagnosis of COPD also associated with an increased risk of postoperative pulmonary complications, but the significance of this finding is unclear given there were only 2 patients with this diagnosis, and thus laparoscopic surgery should not be avoided in this patient population. Cardiac history, BMI, and smoking status were not associated with postoperative pulmonary complications in patients undergoing laparoscopic surgery. In the group of patients found to be at increased risk of pulmonary complications following laparoscopic surgery, an emphasis should be placed on lung expansion interventions such as incentive spirometry and deep breathing excercises post surgery [20].

Our findings in patients undergoing laparoscopic surgery differ from findings of other studies that have evaluated postoperative pulmonary complications in patients undergoing laparotomy. Because postoperative pulmonary complication rates have been extensively published in patients undergoing laparotomy, we chose to exclude these patients and focus purely on pulmonary and upper respiratory complication rates in laparoscopy. We found that smoking history did not affect the complication rate, whereas previous studies have shown that in patients undergoing laparotomy, pulmonary complications are at least twice as common in cigarette smokers [3, 13, 21, 22]. Patients in our study who were current or past smokers did not receive any additional testing, medications, or treatments prior to undergoing a surgical procedure. Postoperative pulmonary complication rates of up to 23% have been reported among smokers undergoing laparotomy, compared to rates of 4.9% to 6.3% in never smokers [3, 13, 21, 22]. In addition, Bluman et al. found that among patients undergoing elective general, orthopedic, urologic, or cardiovascular surgery, smokers were six times as likely to develop postoperative pulmonary complications as were never smokers. Another major finding of that same study was that current smokers who reduced their cigarette consumption prior to surgery had nearly seven times the risk of developing a postoperative pulmonary complication compared with smokers who did not reduce cigarette consumption [3]. Another study has demonstrated similar results, with preoperative smoking cessation within 6 weeks of laparotomy leading to an increased risk of postoperative pulmonary complications [18]. This phenomenon is thought to be due to increased tracheobronchial secretions and ineffective sputum removal from altered respiratory epithelium and poor ciliary activity seen in smokers [2, 18].

Our findings that the rate of postoperative pulmonary complications among smokers undergoing laparoscopic gynecologic surgery was lower than previously published complication rates in smokers undergoing laparotomy has significant clinical implications. A reduction in the complication rate can lead to decreased patient morbidity and mortality. In addition, pulmonary complications contribute to prolonged hospital stay and additional health care costs. Our findings suggest that in smokers scheduled for surgery, laparoscopy should be considered the method of choice when feasible.

The current study is a retrospective review, and as such, suffers from the limitations of retrospective studies. We examined postoperative pulmonary complications among surgical patients at a major tertiary referral center, reporting only on patients with available follow-up data. We did not have information on the intensity and duration of smoking for past and current smokers. In addition, a heterogeneous population of patients undergoing abdominal surgery was studied. Complications were measured within 30 days, but we were unable to account for the possibility of patients either starting or stopping smoking after surgery. Also of note, patients who were considered to be at a higher risk of perioperative complications might not have undergone laparoscopy or even laparotomy. Therefore, our population is a population deemed to be adequate candidates for laparoscopic surgery based on preoperative risk assessment.

In summary, our study demonstrates a low overall incidence of postoperative pulmonary and upper respiratory complications among patients undergoing laparoscopic gynecologic surgery, with smoking history having no effect on the pulmonary complication rate. To the best of our knowledge, this is the first study to evaluate the effects of preoperative smoking on postoperative pulmonary complications in patients following laparoscopic abdominal surgery.

Highlights.

  • Smoking history does not appear to impact postoperative pulmonary complications in this cohort of patients undergoing laparoscopic gynecologic surgery.

  • Pulmonary complications after laparoscopy are lower than those reported after laparotomy.

  • The development of a pulmonary complication translated into a significantly longer hospital stay.

Acknowledgement

The authors wish to thank Ms. Stephanie Deming for her editorial assistance with this manuscript. This research is supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant, CA016672.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest statement: I have no conflicts of interest to report.

References

  • 1.State-specific smoking-attributable mortality and years of potential life lost--United States, 2000–2004. MMWR Morb Mortal Wkly Rep. 2009;58:29–33. [PubMed] [Google Scholar]
  • 2.Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet. 2002;359:114–117. doi: 10.1016/S0140-6736(02)07369-5. [DOI] [PubMed] [Google Scholar]
  • 3.Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998;113:883–889. doi: 10.1378/chest.113.4.883. [DOI] [PubMed] [Google Scholar]
  • 4.Wetterslev J, Hansen EG, Kamp-Jensen M, Roikjaer O, Kanstrup IL. PaO2 during anaesthesia and years of smoking predict late postoperative hypoxaemia and complications after upper abdominal surgery in patients without preoperative cardiopulmonary dysfunction. Acta Anaesthesiol Scand. 2000;44:9–16. doi: 10.1034/j.1399-6576.2000.440103.x. [DOI] [PubMed] [Google Scholar]
  • 5.Moller AM, Maaloe R, Pedersen T. Postoperative intensive care admittance: the role of tobacco smoking. Acta Anaesthesiol Scand. 2001;45:345–348. doi: 10.1034/j.1399-6576.2001.045003345.x. [DOI] [PubMed] [Google Scholar]
  • 6.Schwilk B, Bothner U, Schraag S, Georgieff M. Perioperative respiratory events in smokers and nonsmokers undergoing general anaesthesia. Acta Anaesthesiol Scand. 1997;41:348–355. doi: 10.1111/j.1399-6576.1997.tb04697.x. [DOI] [PubMed] [Google Scholar]
  • 7.Ephgrave KS, Kleiman-Wexler R, Pfaller M, Booth B, Werkmeister L, Young S. Postoperative pneumonia: a prospective study of risk factors and morbidity. Surgery. 1993;114:815–819. discussion 9–21. [PubMed] [Google Scholar]
  • 8.Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp J, Page CP. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. Journal of general internal medicine. 1995;10:671–678. doi: 10.1007/BF02602761. [DOI] [PubMed] [Google Scholar]
  • 9.Hall JC, Tarala RA, Hall JL, Mander J. A multivariate analysis of the risk of pulmonary complications after laparotomy. Chest. 1991;99:923–927. doi: 10.1378/chest.99.4.923. [DOI] [PubMed] [Google Scholar]
  • 10.Mohr DN, Jett JR. Preoperative evaluation of pulmonary risk factors. J Gen Intern Med. 1988;3:277–287. doi: 10.1007/BF02596344. [DOI] [PubMed] [Google Scholar]
  • 11.Ford GT, Rosenal TW, Clergue F, Whitelaw WA. Respiratory physiology in upper abdominal surgery. Clin Chest Med. 1993;14:237–252. [PubMed] [Google Scholar]
  • 12.Strandberg A, Tokics L, Brismar B, Lundquist H, Hedenstierna G. Constitutional factors promoting development of atelectasis during anaesthesia. Acta Anaesthesiol Scand. 1987;31:21–24. doi: 10.1111/j.1399-6576.1987.tb02513.x. [DOI] [PubMed] [Google Scholar]
  • 13.Brooks-Brunn JA. Predictors of postoperative pulmonary complications following abdominal surgery. Chest. 1997;111:564–571. doi: 10.1378/chest.111.3.564. [DOI] [PubMed] [Google Scholar]
  • 14.Dales RE, Dionne G, Leech JA, Lunau M, Schweitzer I. Preoperative prediction of pulmonary complications following thoracic surgery. Chest. 1993;104:155–159. doi: 10.1378/chest.104.1.155. [DOI] [PubMed] [Google Scholar]
  • 15.Poe RH, Kallay MC, Dass T, Celebic A. Can postoperative pulmonary complications after elective cholecystectomy be predicted? Am J Med Sci. 1988;295:29–34. doi: 10.1097/00000441-198801000-00007. [DOI] [PubMed] [Google Scholar]
  • 16.Nagelmann A, Tonnov A, Laks T, Sepper R, Prikk K. Lung Dysfunction of Chronic Smokers with No Signs of COPD. COPD. 2011 doi: 10.3109/15412555.2011.565090. [DOI] [PubMed] [Google Scholar]
  • 17.Rodrigo C. The effects of cigarette smoking on anesthesia. Anesth Prog. 2000;47:143–150. [PMC free article] [PubMed] [Google Scholar]
  • 18.Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc. 1989;64:609–616. doi: 10.1016/s0025-6196(12)65337-3. [DOI] [PubMed] [Google Scholar]
  • 19.Harman E, Lillington G. Pulmonary risk factors in surgery. Med Clin North Am. 1979;63:1289–1298. doi: 10.1016/s0025-7125(16)31641-8. [DOI] [PubMed] [Google Scholar]
  • 20.Lawrence VA, Cornell JE, Smetana GW. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006;144:596–608. doi: 10.7326/0003-4819-144-8-200604180-00011. [DOI] [PubMed] [Google Scholar]
  • 21.Wightman JA. A prospective survey of the incidence of postoperative pulmonary complications. Br J Surg. 1968;55:85–91. doi: 10.1002/bjs.1800550202. [DOI] [PubMed] [Google Scholar]
  • 22.Sakai RL, Abrao GM, Ayres JF, Vianna PT, Carvalho LR, Castiglia YM. Prognostic factors for perioperative pulmonary events among patients undergoing upper abdominal surgery. Sao Paulo Med J. 2007;125:315–321. doi: 10.1590/S1516-31802007000600003. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES